Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Novartis' Sandoz Jobs on the Chopping Block

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

The first of the pink slips at Sandoz' generic-drug manufacturing facility in Broomfield, Colo. have been handed out. Source: BioSpace

Continue ReadingNovartis' Sandoz Jobs on the Chopping Block

Neuro Startup Makes Debut With $20.9M From Novo, Johnson & Johnson

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Syndesi will work to modulate the synaptic vesicle protein SV2A. Source: BioSpace

Continue ReadingNeuro Startup Makes Debut With $20.9M From Novo, Johnson & Johnson

Genomics Startup Emerges From Stealth Mode By Leading Harvard Geneticist

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Nebula Genomic plans to offer inexpensive genetic testing, but allow the consumer to own their own genetic data. Source: BioSpace

Continue ReadingGenomics Startup Emerges From Stealth Mode By Leading Harvard Geneticist

ImmunoPrecise Brings on New CEO

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

ImmunoPrecise announces the appointment of Dr. Jennifer Bath, as the new President and CEO of the Company effective February 21, 2018. Source: BioSpace

Continue ReadingImmunoPrecise Brings on New CEO

Boston-Based Biotech Inks Immuno-Oncology Pact With Seattle Genetics

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Shares of Pieris have climbed more than 10 percent this morning after the company announced it inked a multi-program immuno-oncology collaboration with Seattle Genetics. Source: BioSpace

Continue ReadingBoston-Based Biotech Inks Immuno-Oncology Pact With Seattle Genetics

Teva CEO Says 2018 Will Be a Year of Falling Sales and Profits

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Less than two months into the year, Teva's new chief has already effectively written off a recovery for 2018. Source: BioSpace

Continue ReadingTeva CEO Says 2018 Will Be a Year of Falling Sales and Profits

Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Elastagen's revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin. Source: BioSpace

Continue ReadingAllergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

Clinical-Stage Biotech Stock Might Outperform Amgen

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

This biotech could potentially could be a better value. Source: BioSpace

Continue ReadingClinical-Stage Biotech Stock Might Outperform Amgen

Teva's CGRP Migraine Med Hits a Stumbling Block

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

It's start­ing to feel like Teva can't catch a break. Source: BioSpace

Continue ReadingTeva's CGRP Migraine Med Hits a Stumbling Block

Boehringer Ingelheim Ditches Phase II Alzheimer's Program

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Another potential treatment for Alzheimer's disease has been tossed into the rubbish bin. Source: BioSpace

Continue ReadingBoehringer Ingelheim Ditches Phase II Alzheimer's Program
  • Go to the previous page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 26
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company